TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

Arnaud Scherpereel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.